Browse by Audience
Skip to content
Papers of the Week
Immediate adverse reactions to intravenous immunoglobulin in primary immune deficiencies: a single center experience.
Abstract
Adverse reactions related to intravenous immunoglobulin (IVIG) infusions vary from 1 to 81%, with an average of 20%. They may be classified as immediate; occurring during the infusion itself or delayed; occurring after the infusion has been ceased. In the present study, we aimed to evaluate the frequency of immediate adverse reactions due to IVIG infusions in primary immune deficiency (PID) patients.